Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabotropic glutamate receptors in stem/progenitor cells.
Melchiorri D, Cappuccio I, Ciceroni C, Spinsanti P, Mosillo P, Sarichelou I, Sale P, Nicoletti F. Melchiorri D, et al. Among authors: ciceroni c. Neuropharmacology. 2007 Sep;53(4):473-80. doi: 10.1016/j.neuropharm.2007.05.031. Epub 2007 Jun 29. Neuropharmacology. 2007. PMID: 17675103 Review.
Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells.
Ciceroni C, Arcella A, Mosillo P, Battaglia G, Mastrantoni E, Oliva MA, Carpinelli G, Santoro F, Sale P, Ricci-Vitiani L, De Maria R, Pallini R, Giangaspero F, Nicoletti F, Melchiorri D. Ciceroni C, et al. Neuropharmacology. 2008 Sep;55(4):568-76. doi: 10.1016/j.neuropharm.2008.06.064. Epub 2008 Jul 8. Neuropharmacology. 2008. PMID: 18621067
Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas.
Ciceroni C, Bonelli M, Mastrantoni E, Niccolini C, Laurenza M, Larocca LM, Pallini R, Traficante A, Spinsanti P, Ricci-Vitiani L, Arcella A, De Maria R, Nicoletti F, Battaglia G, Melchiorri D. Ciceroni C, et al. Cell Death Differ. 2013 Mar;20(3):396-407. doi: 10.1038/cdd.2012.150. Epub 2012 Nov 23. Cell Death Differ. 2013. PMID: 23175182 Free PMC article.
The European Medicines Agency Review of Pertuzumab for the treatment of adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer: summary of the scientific assessment of the committee for medicinal products for human use.
Boix-Perales H, Borregaard J, Jensen KB, Ersbøll J, Galluzzo S, Giuliani R, Ciceroni C, Melchiorri D, Salmonson T, Bergh J, Schellens JH, Pignatti F. Boix-Perales H, et al. Among authors: ciceroni c. Oncologist. 2014 Jul;19(7):766-73. doi: 10.1634/theoncologist.2013-0348. Epub 2014 Jun 13. Oncologist. 2014. PMID: 24928613 Free PMC article. Review.
Marginal donors in liver transplantation.
Tisone G, Manzia TM, Zazza S, De Liguori Carino N, Ciceroni C, De Luca I, Toti L, Casciani CU. Tisone G, et al. Among authors: ciceroni c. Transplant Proc. 2004 Apr;36(3):525-6. doi: 10.1016/j.transproceed.2004.02.022. Transplant Proc. 2004. PMID: 15110580
14 results